Burrowing through the heterogeneity

Review of mouse models of PTCL-NOS

Christine E Cutucache, Tyler A. Herek

Research output: Contribution to journalShort survey

2 Citations (Scopus)

Abstract

Currently, there are 19 different peripheral T-cell lymphoma (PTCL) entities recognized by the World Health Organization; however, ~70% of PTCL diagnoses fall within one of three subtypes [i.e., peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), anaplastic large-cell lymphoma, and angioimmunoblastic T-cell lymphoma]. PTCL-NOS is a grouping of extra-thymic neoplasms that represent a challenging and heterogeneous subset of non-Hodgkin's lymphomas. Research into peripheral T-cell lymphomas has been cumbersome as the lack of defining cytogenetic, histological, and molecular features has stymied diagnosis and treatment of these diseases. Similarly, the lacks of genetically manipulated murine models that faithfully recapitulate disease characteristics were absent prior to the turn of the century. Herein, we review the literature concerning existing mouse models for PTLC-NOS, while paying particular attention to the etiology of this heterogeneous disease.

Original languageEnglish (US)
Article number206
JournalFrontiers in Oncology
Volume7
Issue numberSEP
DOIs
StatePublished - Sep 26 2016

Fingerprint

Peripheral T-Cell Lymphoma
Thymus Neoplasms
Anaplastic Large-Cell Lymphoma
T-Cell Lymphoma
Cytogenetics
Non-Hodgkin's Lymphoma
Research

Keywords

  • Genetically engineered
  • Mouse models
  • Neoplasms
  • PTCL-NOS
  • T-cell lymphoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Burrowing through the heterogeneity : Review of mouse models of PTCL-NOS. / Cutucache, Christine E; Herek, Tyler A.

In: Frontiers in Oncology, Vol. 7, No. SEP, 206, 26.09.2016.

Research output: Contribution to journalShort survey

@article{4c8f40af9d7a467599cccc16d2cb269e,
title = "Burrowing through the heterogeneity: Review of mouse models of PTCL-NOS",
abstract = "Currently, there are 19 different peripheral T-cell lymphoma (PTCL) entities recognized by the World Health Organization; however, ~70{\%} of PTCL diagnoses fall within one of three subtypes [i.e., peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), anaplastic large-cell lymphoma, and angioimmunoblastic T-cell lymphoma]. PTCL-NOS is a grouping of extra-thymic neoplasms that represent a challenging and heterogeneous subset of non-Hodgkin's lymphomas. Research into peripheral T-cell lymphomas has been cumbersome as the lack of defining cytogenetic, histological, and molecular features has stymied diagnosis and treatment of these diseases. Similarly, the lacks of genetically manipulated murine models that faithfully recapitulate disease characteristics were absent prior to the turn of the century. Herein, we review the literature concerning existing mouse models for PTLC-NOS, while paying particular attention to the etiology of this heterogeneous disease.",
keywords = "Genetically engineered, Mouse models, Neoplasms, PTCL-NOS, T-cell lymphoma",
author = "Cutucache, {Christine E} and Herek, {Tyler A.}",
year = "2016",
month = "9",
day = "26",
doi = "10.3389/fonc.2016.00206",
language = "English (US)",
volume = "7",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

TY - JOUR

T1 - Burrowing through the heterogeneity

T2 - Review of mouse models of PTCL-NOS

AU - Cutucache, Christine E

AU - Herek, Tyler A.

PY - 2016/9/26

Y1 - 2016/9/26

N2 - Currently, there are 19 different peripheral T-cell lymphoma (PTCL) entities recognized by the World Health Organization; however, ~70% of PTCL diagnoses fall within one of three subtypes [i.e., peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), anaplastic large-cell lymphoma, and angioimmunoblastic T-cell lymphoma]. PTCL-NOS is a grouping of extra-thymic neoplasms that represent a challenging and heterogeneous subset of non-Hodgkin's lymphomas. Research into peripheral T-cell lymphomas has been cumbersome as the lack of defining cytogenetic, histological, and molecular features has stymied diagnosis and treatment of these diseases. Similarly, the lacks of genetically manipulated murine models that faithfully recapitulate disease characteristics were absent prior to the turn of the century. Herein, we review the literature concerning existing mouse models for PTLC-NOS, while paying particular attention to the etiology of this heterogeneous disease.

AB - Currently, there are 19 different peripheral T-cell lymphoma (PTCL) entities recognized by the World Health Organization; however, ~70% of PTCL diagnoses fall within one of three subtypes [i.e., peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), anaplastic large-cell lymphoma, and angioimmunoblastic T-cell lymphoma]. PTCL-NOS is a grouping of extra-thymic neoplasms that represent a challenging and heterogeneous subset of non-Hodgkin's lymphomas. Research into peripheral T-cell lymphomas has been cumbersome as the lack of defining cytogenetic, histological, and molecular features has stymied diagnosis and treatment of these diseases. Similarly, the lacks of genetically manipulated murine models that faithfully recapitulate disease characteristics were absent prior to the turn of the century. Herein, we review the literature concerning existing mouse models for PTLC-NOS, while paying particular attention to the etiology of this heterogeneous disease.

KW - Genetically engineered

KW - Mouse models

KW - Neoplasms

KW - PTCL-NOS

KW - T-cell lymphoma

UR - http://www.scopus.com/inward/record.url?scp=84991826692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991826692&partnerID=8YFLogxK

U2 - 10.3389/fonc.2016.00206

DO - 10.3389/fonc.2016.00206

M3 - Short survey

VL - 7

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - SEP

M1 - 206

ER -